278 related articles for article (PubMed ID: 8549951)
1. Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stages.
Martinez JA; Prevot S; Nordlinger B; Nguyen TM; Lacarriere Y; Munier A; Lascu I; Vaillant JC; Capeau J; Lacombe ML
Gut; 1995 Nov; 37(5):712-20. PubMed ID: 8549951
[TBL] [Abstract][Full Text] [Related]
2. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
[TBL] [Abstract][Full Text] [Related]
3. High level of Nm23-H1 gene expression is associated with local colorectal cancer progression not with metastases.
Zeng ZS; Hsu S; Zhang ZF; Cohen AM; Enker WE; Turnbull AA; Guillem JG
Br J Cancer; 1994 Nov; 70(5):1025-30. PubMed ID: 7947079
[TBL] [Abstract][Full Text] [Related]
4. NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma.
Iizuka N; Oka M; Noma T; Nakazawa A; Hirose K; Suzuki T
Cancer Res; 1995 Feb; 55(3):652-7. PubMed ID: 7530600
[TBL] [Abstract][Full Text] [Related]
5. Inverse association of nm23-H1 expression by colorectal cancer with liver metastasis.
Yamaguchi A; Urano T; Fushida S; Furukawa K; Nishimura G; Yonemura Y; Miyazaki I; Nakagawara G; Shiku H
Br J Cancer; 1993 Nov; 68(5):1020-4. PubMed ID: 8217591
[TBL] [Abstract][Full Text] [Related]
6. Expression and mutational analysis of Nm23-H1 in liver metastases of colorectal cancer.
Heide I; Thiede C; Poppe K; de Kant E; Huhn D; Rochlitz C
Br J Cancer; 1994 Dec; 70(6):1267-71. PubMed ID: 7981087
[TBL] [Abstract][Full Text] [Related]
7. Analysis of both NM23-h1 and NM23-H2 expression identifies "at-risk" patients with colorectal cancer.
Brenner AS; Thebo JS; Senagore AJ; Duepree HJ; Gramlich T; Ormsby A; Lavery IC; Fazio VW
Am Surg; 2003 Mar; 69(3):203-8; discussion 208. PubMed ID: 12678475
[TBL] [Abstract][Full Text] [Related]
8. Expression of human nm23-H1 and nm23-H2 proteins in hepatocellular carcinoma.
Yamaguchi A; Urano T; Goi T; Takeuchi K; Niimoto S; Nakagawara G; Furukawa K; Shiku H
Cancer; 1994 May; 73(9):2280-4. PubMed ID: 8168032
[TBL] [Abstract][Full Text] [Related]
9. Expression of nm23-H1 predicts lymph node involvement in colorectal carcinoma.
Tannapfel A; Köckerling F; Katalinic A; Wittekind C
Dis Colon Rectum; 1995 Jun; 38(6):651-4. PubMed ID: 7774480
[TBL] [Abstract][Full Text] [Related]
10. High levels of nm23-H1 and nm23-H2 messenger RNA in human squamous-cell lung carcinoma are associated with poor differentiation and advanced tumor stages.
Engel M; Theisinger B; Seib T; Seitz G; Huwer H; Zang KD; Welter C; Dooley S
Int J Cancer; 1993 Sep; 55(3):375-9. PubMed ID: 8375920
[TBL] [Abstract][Full Text] [Related]
11. High frequency of concomitant nm23-H1 and E-cadherin transcriptional inactivation in primary non-inheriting colorectal carcinomas.
Garinis GA; Manolis EN; Spanakis NE; Patrinos GP; Peros G; Menounos PG
J Mol Med (Berl); 2003 Apr; 81(4):256-63. PubMed ID: 12684753
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of the loss of heterozygosity of Nm23-H1 and p53 genes in human colorectal carcinomas.
Campo E; Miquel R; Jares P; Bosch F; Juan M; Leone A; Vives J; Cardesa A; Yague J
Cancer; 1994 Jun; 73(12):2913-21. PubMed ID: 8199988
[TBL] [Abstract][Full Text] [Related]
13. NM23-H1 immunostaining is inversely associated with tumour staging but not overall survival or disease recurrence in colorectal carcinomas.
Cheah PY; Cao X; Eu KW; Seow-Choen F
Br J Cancer; 1998 Apr; 77(7):1164-8. PubMed ID: 9569056
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of nm23-H4 RNA in colorectal and renal tumours.
Hayer J; Engel M; Seifert M; Seitz G; Welter C
Anticancer Res; 2001; 21(4A):2821-5. PubMed ID: 11724361
[TBL] [Abstract][Full Text] [Related]
15. NM-23 H1 immunohistochemistry is not useful as predictor of metastatic potential of colorectal cancer.
Lindmark G
Br J Cancer; 1996 Nov; 74(9):1413-8. PubMed ID: 8912537
[TBL] [Abstract][Full Text] [Related]
16. Expression of nm23-H1 and nm23-H2 protein in endometrial carcinoma.
Watanabe J; Sato Y; Kuramoto H; Kameya T
Br J Cancer; 1995 Dec; 72(6):1469-73. PubMed ID: 8519661
[TBL] [Abstract][Full Text] [Related]
17. High nm23-H1/NDPK-A expression in Ewing tumors: paradoxical immunohistochemical reactivity and lack of prognostic significance.
Aryee DN; Ströbel T; Kos K; Salzer-Kuntschik M; Zoubek A; Veron M; Ambros IM; Traincart F; Gadner H; Kovar H
Int J Cancer; 1995 Apr; 64(2):104-11. PubMed ID: 7542225
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of NDP kinase nm23 associated with ploidy image analysis in colorectal cancer.
Giarnieri E; Alderisio M; Valli C; Vecchione A; Forte A; Turano R; Pulcini M
Anticancer Res; 1995; 15(5B):2049-53. PubMed ID: 8572601
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of nucleoside diphosphate/kinase A/nm23-H1 protein in human lung tumors: association with tumor progression in squamous carcinoma.
Gazzeri S; Brambilla E; Negoescu A; Thoraval D; Veron M; Moro D; Brambilla C
Lab Invest; 1996 Jan; 74(1):158-67. PubMed ID: 8569178
[TBL] [Abstract][Full Text] [Related]
20. Expression of nm23-H1 and nm23-H2 proteins in prostate carcinoma.
Konishi N; Nakaoka S; Tsuzuki T; Matsumoto K; Kitahori Y; Hiasa Y; Urano T; Shiku H
Jpn J Cancer Res; 1993 Oct; 84(10):1050-4. PubMed ID: 7693635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]